Hosted on MSN19m
Here's Why Keros Therapeutics (KROS) is Poised for a Turnaround After Losing -39.17% in 4 WeeksKeros Therapeutics, Inc. (KROS) has been on a downward spiral lately with significant selling pressure. After declining 39.2% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback